NCT07219212 2026-03-13LUMIRAYJohnson & Johnson Enterprise Innovation Inc.Phase 1 Recruiting30 enrolled
NCT02937272 2025-10-20A Study of LY3200882 in Participants With Solid TumorsEli Lilly and CompanyPhase 1 Active not recruiting223 enrolled
NCT06056310 2025-09-29Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)EMD SeronoPhase 1 Terminated18 enrolled 9 charts
NCT06011291 2023-10-27A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck CancerCSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 1 Unknown73 enrolled
NCT02555644 2019-02-15A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck CancerEli Lilly and CompanyPhase 1 Completed70 enrolled